During the past 3 years, we have experienced a major revolution in the biological sciences resulting from a tremendous flux of information generated by genomesequencing efforts. Our understanding of microorganisms, the metabolic processes they catalyze, the genetic apparatuses encoding cellular proteinaceous constituents, and the pathological conditions caused by these organisms has greatly benefited from the availability of complete microbial genomic sequences. Many research institutes around the world are now devoting their efforts solely to genome sequencing and to analysis of the data produced. Dozens of international conferences have been held with the primary purpose of keeping the scientific community abreast of recent developments. In this Update I will summarize some of the exciting information reported at a recent conference on microbial genomics.
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Compared with microbe genomics, plant genomics is still in its infancy, since the sequencing of only the Arabidopsis genome is currently under way (Bevan et al., 1998) . However, within a few years we can expect that the genomic sequences of at least two plants, Arabidopsis and rice (Oryza sativa), will be available. Meanwhile, as of January 1998, 12 microbial genomes have already been sequenced and published. These include genomes of representative organisms from the three domains of life: bacteria, archaea, and eukarya. The genomes of one eukaryote (the brewers' yeast Saccharomyces cerevisiae) as well as three archaea and eight bacteria have been completely sequenced. By examining what has been learned from sequencing of microbial genomes, we can get some idea about what kinds of information we can expect from plant genome-sequencing efforts.
MICROBIAL GENOME SEQUENCING
Most of the bacterial genomes that have been sequenced are small, of 2 Mbp or less. However, three large bacterial genomes have been sequenced: those of the prototypic gram-negative bacterium Escherichia coli (Blattner et al., 1997) ; the best-characterized gram-positive bacterium, Bacillus subtilis (Kunst et al., 1997) ; and a representative cyanobacterium, Synechocystis PCC6803 (Kaneko et al., 1996) . In addition, six microbial genomes have been completely sequenced but not yet published. Pathogens with fully sequenced genomes include Mycobacterium tuberculosis, the causative agent of tuberculosis; Treponema pallidum, the spirochete that causes syphilis; and Borrelia burgdorferi, another spirochete that causes Lyme disease. Two interesting nonpathogens that have recently been sequenced are Deinococcus radiodurans, the organism reported to be most resistant to UV irradiation, and Aquifex aeolicus, a marine hyperthermophile capable of growth at 95°C. Based on 16S RNA analyses, A. aeolicus may represent the deepest lineage within the bacterial domain, and its genome may therefore provide clues about primitive prokaryotic lifeforms that existed billions of years ago.
More than 50 microbial genomes are currently being sequenced. These include the genomes of virtually every major pathogen. Industrially important bacteria such as Clostridium acetobutylicum, a principal producer of organic solvents, are also being sequenced, as is the deep-sea manganese-oxidizing bacterium Shewanella putrefaciens. The sequence of the first animal genome, that of the worm Caenorhabdeitis elegans, is expected to be completed in the middle of this year (July, 1998) . Although only 3% of the human genome has been sequenced, this tiny fraction of the human genome represents more DNA than that of all of the completed microbial genomes sequenced to date. Table I summarizes some of the most impressive genome-sequencing efforts completed by the end of 1997. The first organism to have its genome sequenced was Haemophilus influenzae (Fleischmann et al., 1995) . It has a genome size of 1.8 Mbp encoding 1743 recognized genes. One laboratory at the Institute for Genomic Research, involving about 40 people, completed the project in 1 year. B. subtilis, with a genome of 4.2 Mbp, was sequenced by an international consortium of 46 laboratories involving about 160 people in 5 years (Kunst et al., 1997) .
S. cerevisiae possesses about 13 Mbp of DNA, and 12 Mbp of this DNA has been fully sequenced. The remaining 1 Mbp consists of repetitive rDNA (encoding rRNA molecules) representing more than 100 repeats. This repetitive DNA was not sequenced as part of the yeast-sequencing effort partly for technical reasons, and partly because it was expected to yield little new information. Ninety-six laboratories and 640 people completed this project in 6 years (Goffeau et al., 1997) . The prototypical bacterium E. coli (4.6 Mbp) was sequenced by a single laboratory in an effort involving 17 people, but the project took about 10 years (Blattner et al., 1997) . Because of recent technological advances, it is estimated that a microbial genome of about 2 Mbp can now be fully sequenced in 1 year by a single laboratory of 6 people with an expenditure of less than $1 million.
GENOME SEQUENCING LEADS TO THE IDENTIFICATION OF NEW PROTEINS
Tremendous benefits have resulted from the microbial genome-sequencing efforts completed to date (Table II) . For example, important new proteins have been identified. Owen White at the Institute for Genomic Research reported that D. radiodurans is the first nonphotosynthetic organism to be shown to possess the light-sensing protein phytochrome. In D. radiodurans this molecule may function to regulate the synthesis of pigments that protect the organism from irradiation, and it also has a novel type of RecA protein involved in DNA repair-related recombination.
Richard Roberts of New England Biolabs analyzed various genomes for DNA restriction-modification systems, enzyme systems that protect organisms from the potentially detrimental effects of foreign DNA (such as that of viruses). It was found that although B. subtilis and E. coli possess 3 to 4 such restriction-modification systems, some pathogenic bacteria have far more. Thus, H. influenzae has 7, Neisseria gonorrhoeae has 18, and Helicobacter pylori, which is a causative agent of peptic ulcers, has 23. The physiological significance attributed to the possession of large numbers of such systems in small-genome bacteria is a point of debate.
Entirely new families of protein paralogs (families of proteins arising by gene duplication within a single organism) have been revealed by genome sequencing. For example, Claire Fraser, Sherwood Casjens, and Steven Norris reported that the genomes of the two pathogenic spirochetes T. pallidum and B. burgdorferi both exhibit large families of species-specific paralogs of unknown function. The same has been observed for methanogenic (methaneproducing) archaea. In the case of B. subtilis, a large family of Bacillus-specific protein paralogs have been identified as "Rap" phosphatases that release phosphate from phosphorylated aspartyl residues in response to regulatory proteins. These regulatory proteins control the initiation of sporulation, a gram-positive bacterial cell-differentiation process that leads to the generation of thick-walled, metabolically inert, environmentally resistant spores (Perego et al., 1994 (Perego et al., , 1996 .
DISCOVERY OF NEW METABOLIC PATHWAYS
Entirely new metabolic pathways have been revealed by genome sequencing. Tyrrell Conway reported the discovery of a previously unrecognized pathway in E. coli for the metabolism of the sugar acid idonate, a compound that had not been known to be a substrate for the growth of this bacterium (C. Bausch, N. Peekhaus, C. Utz, T. Blais, E. Murray, T. Lowary, and T. Conway, unpublished data). Additionally, analysis of several bacterial genomes showed that many bacteria have all of the requisite enzymes of the ribulose-monophosphate-hexulose-monophosphate pathway, a pathway for the interconversion of five-and sixcarbon sugars (Reizer et al., 1997) . Such a pathway had been previously demonstrated only in methanogenic bacteria. Finally, Owen White reported evidence that D. radiodurans has a novel pathway for the efficient repair of double-stranded DNA breaks, a fact that explains the ability of this octaploid organism to repair more than 150 double-stranded DNA breaks in its genome without loss of viability (Battista, 1997) .
The availability of a complete genomic sequence allows one to estimate the total metabolic capability of an organism. For example, knowledge of the complete gene complement permits estimation of the nutrients that can be taken up by the cell. Such knowledge reflects the natural lifestyle of the organism, and hence, ecological deductions and inferences can be made regarding the use of the bacterium for purposes of bioremediation (Clayton et al., 1997; Paulsen et al., 1998) .
Based on the complement of genes encoded within microbial genomes, Peter Karp of the Pangea Corporation in Oakland, CA, and his co-workers have created "EcoCyc" for E. coli and "HinCyc" for H. influenzae, which are computerized displays of the complete metabolic pathways of 
COMPARATIVE GENOMICS YIELDS NEW CLUES ABOUT PATHOGENESIS AND HORIZONTAL GENE TRANSFER
Virulence factors and novel mechanisms of pathogenesis have been revealed as a result of the development of the new discipline of comparative genomics. Thus, Fred Blattner, who recently sequenced a pathogenic E. coli strain and compared it with the nonpathogenic E. coli K12 strain commonly used for laboratory research, reported that the former bacterium possesses 1.2 Mbp more DNA than the latter, an approximately 20% increase in genomic size. This additional genetic material codes for virulence factorbearing prophage, a virulence plasmid, and a "pathogenicity island" that allows the bacteria to secrete toxic proteins directly from the bacterial cytoplasm into that of the host animal cell (see Groisman and Ochman, 1996) . In addition, three new tRNAs, a eukaryotic-type Ser/Thr protein kinase, and a novel iron-transport system, all possibly important for pathogenicity, were revealed.
Potential drug targets were identified and studied. Lynn Miesel reported on studies characterizing the targets of the antituberculosis drug isoniazid. This drug appears to inhibit the growth of M. tuberculosis by blocking the function of a biosynthetic enzyme that makes a cell-surface fatty acid called mycolic acid. Isoniazid thereby disrupts the outer protective layer of this fastidious bacterium, rendering it sensitive to host defense mechanisms.
Horizontal gene transfer between related gram-negative bacteria could be established using the comparative genomics approach. Pathogenicity islands, encoding virulence factor genes and the apparatus for their transfer to host cells, have now been identified in many bacteria (Groisman and Ochman, 1996) . Fred Blattner noted that 30% of the new DNA present in pathogenic E. coli, but lacking in nonpathogenic E. coli, is shared by Yersinia pestis, the causative agent of plague.
GENOMICS, PROTEOMICS, AND BIOINFORMATICS
Tremendous technological advances are being made in the related fields of genomics, proteomics, and bioinformatics (Tables III-V) . In the area of genomics (the study of an organism's gene complement; Table III ), novel chips bearing oligonucleotide probes for analysis of the expression of the complete complement of genes encoded within the genome of an organism have already been used and the results published (DeRisi et al., 1997; Wodicka et al., 1997) . Such a chip costs about $200 and is good for a single information-rich experiment. However, the machine that reads the chip costs about $150,000.
Expression vectors, gene knockouts, and reporter-gene constructs for all of the genes in an organism will soon be available for at least two major experimental organisms, the yeast S. cerevisiae, and the sporulating, gram-positive bacterium B. subtilis. Our laboratory has recently taken advantage of such technology to identify and characterize a protein kinase that controls catabolite repression and carbon metabolism in B. subtilis (Reizer et al., 1998) . In earlier studies we had purified the protein and determined an N-terminal amino acid sequence, but the availability of this sequence was insufficient to allow us to clone the gene. When the complete genome of B. subtilis became available, its identification became almost automatic. Thus, when expression vectors, knockouts, and fusion constructs become available commercially, the academic molecular biologist will be largely obsolete.
In proteomics (the study of an organism's proteins; Table  IV) , technological advances are beginning to have an effect on basic research. Tremendous advances have been made in coupling two-dimensional gel analysis of the total protein complement of an organism to analysis by MS or to N-terminal sequence analysis. Chips are being developed for pico-quantity protein purification based on hydrophobic and ion-exchange chromatography as well as adsorption chromatography.
Rapid procedures for studying protein-protein interactions are being developed. For example, a yeast two-hybrid system has recently been developed for the assay of whole libraries of genes to determine which of the encoded proteins interact with high affinity with a specific test protein (Williams et al., 1998) . Additionally, novel chips for studying protein-ligand interactions are being developed. Finally, in the area of bioinformatics (the computational analysis of genetic and biochemical data; Table V), novel software is being developed for more refined homology searches of the databases, for protein and nucleic acid secondary and tertiary structural predictions, and for protein and DNA motif identification. Many of the programs used routinely in academic laboratories for characterizing families of proteins have been or are now being automated. Such advances will be required to keep up with the exponentially increased volume of sequence data that will be available in the near future.
Genome-sequence analyses have revealed that most of the proteins encoded within the genome of a living organism belong to families of homologous proteins that share a common evolutionary origin and are present in many dissimilar organisms. Some of these families are very large, with hundreds of currently sequenced members (Pao et al., 1998) . Other families are small, with only a few currently sequenced members (Saier, 1998) . By constructing dendrograms (which show approximate relationships of the proteins to each other without providing numerical values for the relative phylogenetic distances that separate them), or instead by constructing phylogenetic trees (which not only cluster the proteins according to their relative degrees of sequence similarity, but also provide quantitative measures of their degrees of relatedness), one can estimate the probability that any two members of a protein family will prove to serve the same function. Phylogenetic trees thus indicate relative degrees of sequence similarity and provide a reliable guide to biochemical function.
WHERE IS GENOMICS GOING?
Where is the new discipline of genomics taking us? Directly into an exciting and ever-expanding new century of scientific discovery. The current sequencing explosion will lead to the development of novel disciplines such as "comparative genomics" and "molecular archaeology" (Table VI). Because about 20% to 30% of each newly sequenced genome consists of genes encoding proteins with no recognizable homologs in the current databases (Koonin et al., 1997) , a tremendous effort must be devoted to the functional identification of these "orphan" proteins. Novel regulatory constraints and virulence mechanisms will be revealed (Ewald, 1996) . New kingdoms of currently unculturable microbes (Bloomfield et al., 1998 ) are likely to be revealed. Discoveries leading to tremendous expansion of industrial applications will be made, and additional novel technological advances will undoubtedly appear in the not-too-distant future. But most importantly, genomics will lead to discoveries currently unforeseen and nearly unfathomable. Even 2 years ago we did not dream that microbial genomes would exhibit the degree of plasticity that has been revealed by genome sequencing, or that the "minimal genome" would be so limited in scope. Living organisms have solved the fundamental problems of life in many diverse ways. It is an exciting time to be working in the biological sciences, and this excitement is largely attributable to developments in genomics. The advances of the future will be limited only by the imaginations of current and future generations of molecular biologists. Sequencing explosion: genome sequencing will become the primary source of biological information Comparative genomics: functional assignments in one organism will be directly applicable to many others Molecular archeology: sequence comparisons and three-dimensional structural analyses will allow deduction of evolutionary origins of most macromolecules Functional identification: many new types of genes must be characterized biochemically and physiologically Regulatory constraints: identification of new genes requires an understanding of how their expression is regulated Virulence mechanisms: novel factors and mechanisms concerned with microbial pathogenesis will be discovered Unculturable organisms: microorganisms that cannot be currently cultured in the laboratory will be characterized Industrial applications: industry will use microorganisms to an ever-increasing degree for the production of useful products Novel technological advances: technologies will be developed for understanding and using the genetic information encoded within microbes Unforeseen discoveries: many novel discoveries will be made in almost every imaginable dimension, with far-reaching consequences
